Clinical Trial Update: A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for GSK4527363 including systemic lupus erythematosus and connective tissue disease-associated interstitial lung disease cohorts; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Connective Tissue Disease-associated Interstitial Lung Disease
• Systemic Lupus Erythematosus

Drugs mentioned

• GSK4527363 (GSK4527363)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Systemic Lupus Erythematosus | Phase 1 | Status: RECRUITING